0001209191-22-021385.txt : 20220328
0001209191-22-021385.hdr.sgml : 20220328
20220328200328
ACCESSION NUMBER: 0001209191-22-021385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20040324
FILED AS OF DATE: 20220328
DATE AS OF CHANGE: 20220328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barrow Robert
CENTRAL INDEX KEY: 0001897557
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40360
FILM NUMBER: 22777060
MAIL ADDRESS:
STREET 1: C/O MIND MEDICINE INC.
STREET 2: ONE WORLD TRADE CENTER, SUITE 8500
CITY: NEW YORK
STATE: NY
ZIP: 10007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc.
CENTRAL INDEX KEY: 0001813814
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1166 ALBERNI STEET
STREET 2: SUITE 1604
CITY: VANCOUVER
STATE: A1
ZIP: V6E 3Z3
BUSINESS PHONE: (212) 220-6633
MAIL ADDRESS:
STREET 1: 1166 ALBERNI STEET
STREET 2: SUITE 1604
CITY: VANCOUVER
STATE: A1
ZIP: V6E 3Z3
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2004-03-24
0
0001813814
Mind Medicine (MindMed) Inc.
MNMD
0001897557
Barrow Robert
C/O MIND MEDICINE (MINDMED), INC.
ONE WORLD TRADE CENTER, SUITE 8500
NEW YORK
NY
10007
1
1
0
0
Chief Executive Officer
Subordinate Voting Shares
2022-03-24
4
A
0
1820000
0.00
A
4033367
D
Stock Option (Right to Buy)
1.18
2022-03-24
4
A
0
2910000
0.00
A
2027-03-23
Subordinate Voting Shares
2910000
6425500
D
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. The RSUs vest in 48 equal monthly installments beginning on April 24, 2022, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date.
The option grant has an exercise price of $1.48 Canadian Dollars. This represents the exercise price in United States Dollars.
The shares subject to the option vest and become exercisable with 1/48th of the total shares vesting monthly over 48 months from the vesting commencement date, March 24, 2022, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date.
/s/ Robert Barrow
2022-03-28